As of May 22
| +0.01 / +1.45%|
The 3 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.90, with a high estimate of 2.00 and a low estimate of 1.25. The median estimate represents a +171.43% increase from the last price of 0.70.
The current consensus among 3 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.